Novavax's stock tumbles 19% after FDA puts clinical hold on COVID and flu vaccine candidates
Novavax Inc.’s stock tumbled 19% early Wednesday after the company said the Food and Drug Administration has placed a clinical hold on its COVID-19-and-flu combination and stand-alone flu vaccine candidates,
KP.3.1.1 is still the dominant COVID-19 variant in the United States as it accounts for nearly 60% of positive cases, but the ...
Moderna was hit with a new patent lawsuit on Wednesday in Delaware federal court from Northwestern University, which accused ...
More than seven million people have died from Covid-19 yet false information about the virus continues to circulate online.
While KP.3.1.1 remains the dominant strain in the U.S., XEC is gaining steam, according to the Centers for Disease Control ...
However, some people may have noticed that the tests will expire soon. The Administration for Strategic Preparedness and ...
Anyone can once again order up to four free COVID-19 tests for use at home from the federal government as flu season picks up ...
A North Carolina State University study found that being hopeful was more effective at managing stress than simple ...
During the COVID-19 public health emergency (PHE) period, excess mortality occurred in all racial and ethnic groups, but ...
People who got COVID-19 early in the pandemic saw their risk of cardiovascular issues double, a new study finds.
The dominant strain of the COVID-19 virus in Arizona right now is a variant called KP.3.1.1, which is part of the FLiRT group ...
XEC is on track to become the new dominant COVID-19 strain this winter. Yale and New Haven experts weigh in on why you should ...
Manitoba struggled last year through the worst flu season in two decades, so this time around, the province is making sure it ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback